# A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)

> clinical trial · VERIFIED · 2026-07-20

Status: ACTIVE_NOT_RECRUITING · Sponsor: AstraZeneca · Condition: Influenza A

- Company: AstraZeneca
- Sector: biotech
- Primary source: https://clinicaltrials.gov/study/NCT07128615

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.